RecruitingNot Applicable

Systemic Treatments for Alopecia Areata Registry

Netherlands10,000 participantsStarted 2024-01-17

Plain-language summary

A multicenter prospective registry (STA2R) is conducted to assess systemic treatments for alopecia areata, focusing on effectiveness, safety, and long-term outcomes.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with alopecia areata; * Starting/using a systemic treatment for alopecia areata; * Informed consent for registry participation obtained from patient and/or caretaker. Exclusion Criteria: * Not sufficiently capable of understanding the Dutch language; * Not willing to participate.

What they're measuring

Effectiveness of systemic treatments

Timeframe: A minimum of 10 years from last patient enrolled (every 3-6 months)

Safety of systemic treatments

Timeframe: A minimum of 10 years from last patient enrolled (every 3-6 months)

Trial details

NCT IDNCT06283316

SponsorErasmus Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2099-12-31

Contact for this trial

DirkJan Hijnen, MD, PhD

0031 10 704 01 10 d.hijnen@erasmusmc.nl

View on ClinicalTrials.gov More Alopecia Areata trials